AGP Picks
View all

Iowa Healthcare Reporter
Provided by AGP

Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 12, 2026

Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis
Aug. 12, 2026

Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis

Indeterminate GlobeNewswire
TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 12, 2026

TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
Aug. 12, 2026

Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
Aug. 12, 2026

Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire
Kamada Announces Planned Transition of Chief Financial Officer
Aug. 12, 2026

Kamada Announces Planned Transition of Chief Financial Officer

Indeterminate GlobeNewswire
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
Aug. 12, 2026

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
Aug. 12, 2026

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer

Indeterminate GlobeNewswire
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
Aug. 12, 2026

Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

Indeterminate GlobeNewswire
Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics
Aug. 12, 2026

Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics

Indeterminate GlobeNewswire
Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
Aug. 12, 2026

Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

Indeterminate GlobeNewswire
Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug. 12, 2026

Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
Aug. 12, 2026

Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones

Indeterminate GlobeNewswire
Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study
Aug. 12, 2026

Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study

Indeterminate GlobeNewswire
Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases
Aug. 12, 2026

Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases

Indeterminate GlobeNewswire
Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
Aug. 12, 2026

Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement

Indeterminate GlobeNewswire
ダーク・ホース・コンサルティング・グループが中国に進出、カン・リウをシニアディレクター兼中国事業責任者に任命
Aug. 12, 2026

ダーク・ホース・コンサルティング・グループが中国に進出、カン・リウをシニアディレクター兼中国事業責任者に任命

Indeterminate GlobeNewswire
다크호스 컨설팅 그룹, 중국 시장 진출하며 강 리우 중국사업 총괄 수석이사 선임
Aug. 12, 2026

다크호스 컨설팅 그룹, 중국 시장 진출하며 강 리우 중국사업 총괄 수석이사 선임

Indeterminate GlobeNewswire
Dark Horse Consulting Group Meluaskan Operasi ke China, Melantik Kang Liu sebagai Pengarah Kanan dan Ketua China
Aug. 12, 2026

Dark Horse Consulting Group Meluaskan Operasi ke China, Melantik Kang Liu sebagai Pengarah Kanan dan Ketua China

Indeterminate GlobeNewswire
Dark Horse Consulting Group 进军中国市场，任命 Kang Liu 为高级总监兼中国区负责人
Aug. 12, 2026

Dark Horse Consulting Group 进军中国市场，任命 Kang Liu 为高级总监兼中国区负责人

Indeterminate GlobeNewswire
Dark Horse Consulting Group 拓展中國市場，任命 Kang Liu 為高級總監兼中國區負責人
Aug. 12, 2026

Dark Horse Consulting Group 拓展中國市場，任命 Kang Liu 為高級總監兼中國區負責人

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Iowa Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.